Didier Hans, Ph.D., P.D. is a co-founder of Synarc, Inc and is currently Head of the Research and Development in the Radiology Department, Nuclear Medicine Division at the University of Geneva, Switzerland.  He has 15 years of Clinical Research experience and is recognized as an expert on the cutting edge of Dual-Energy X-Ray Absorptiometry (DXA) and Quantitative Ultrasound Systems (QUS) technologies.  He has particular expertise in validating and optimizing new technologies as well as developing DXA and ultrasound protocol, quality assurance and training of research assistants for large, multi-center clinical trials.

Dr. Hans has a Ph.D. in human biology and medical physics, with honors, from Claude Bernard University in Lyon, France and was a recipient of the Young Investigators Award from the American Society of Bone and Mineral Research Annual Meeting in 1995.  He also has a Masters of Science degree, with honors, in Medical Physics from Claude Bernard University.  He is an active member of eight international societies and advisory boards. He continues to teach courses in DXA and Osteoporosis and lectures around the world.  Also, he serves as a reviewer for seven international scientific journals, has published more than 80 articles and has contributed chapters to over 20 books.

Dr. Hans was the Director of the Quality Assurance Center for Clinical Research and the Associate Director of Research and Development for the ultrasound unit at the Osteoporosis and Arthritis Research Group (OARG) of the University of California San Francisco, San Francisco CA.  OARG later became Synarc, Inc. Also, he has held similar positions in Europe at the Centre d’Epidémiologie des Ostéoporoses in Lyon, France.  While at d’Epidémiologie des Ostéoporoses, he was Director of the Bone Densitometry and new technologies department, as well as Director of the Quality Control Department.